Baird Medical Investment Holdings Limited (BDMD) - Total Liabilities
Based on the latest financial reports, Baird Medical Investment Holdings Limited (BDMD) has total liabilities worth $41.37 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Baird Medical Investment Holdings Limited - Total Liabilities Trend (2019–2024)
This chart illustrates how Baird Medical Investment Holdings Limited's total liabilities have evolved over time, based on quarterly financial data. See Baird Medical Investment Holdings Limite current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Baird Medical Investment Holdings Limited Competitors by Total Liabilities
The table below lists competitors of Baird Medical Investment Holdings Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Urbanfund Corp
V:UFC
|
Canada | CA$69.01 Million |
|
Sentronic International
TWO:3232
|
Taiwan | NT$423.88 Million |
|
K Way Information
TWO:5201
|
Taiwan | NT$264.47 Million |
|
Dynamic Precision Industry
TWO:8928
|
Taiwan | NT$2.54 Billion |
|
Lite Strategy, Inc.
NASDAQ:LITS
|
USA | $1.07 Million |
|
Daewon Co. Ltd
KQ:007680
|
Korea | ₩219.50 Billion |
|
Studio Mir Co. Ltd.
KQ:408900
|
Korea | ₩3.57 Billion |
|
Tirta Mahakam Resources Tbk
JK:TIRT
|
Indonesia | Rp1.07 Trillion |
Liability Composition Analysis (2019–2024)
This chart breaks down Baird Medical Investment Holdings Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Baird Medical Investment Holdings Limite stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.71 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.16 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.54 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Baird Medical Investment Holdings Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Baird Medical Investment Holdings Limited (2019–2024)
The table below shows the annual total liabilities of Baird Medical Investment Holdings Limited from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $38.20 Million | +81.91% |
| 2023-12-31 | $21.00 Million | +24.71% |
| 2022-12-31 | $16.84 Million | +64.14% |
| 2021-12-31 | $10.26 Million | +0.06% |
| 2020-12-31 | $10.25 Million | -70.14% |
| 2019-12-31 | $34.33 Million | -- |
About Baird Medical Investment Holdings Limited
Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; long microwave ablation needles; and fine microwave ablation needles for the treatment of benign and malignant tumors, in… Read more